much more reliable for these four big biotech companies. For those biotech high fliers, TA might not work. One bad news from FDA can knock them down 20-30% easily and one M&A news can double their price as well.
much more reliable for these four big biotech companies. For those biotech high fliers, TA might not work. One bad news from FDA can knock them down 20-30% easily and one M&A news can double their price as well.
WENXUECITY.COM does not represent or guarantee the truthfulness, accuracy, or reliability of any of communications posted by other users.
Copyright ©1998-2025 wenxuecity.com All rights reserved. Privacy Statement & Terms of Use & User Privacy Protection Policy